Skip to content
value.today

Cell Source, Inc. vs Seres Therapeutics, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Cell Source, Inc. and Seres Therapeutics, Inc. are worth about the same: $20 M and $20 M (market caps of Dec 25, 2022 for Cell Source, Inc. and Oct 30, 2026 for Seres Therapeutics, Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
  • Seres Therapeutics, Inc. made a net profit of $6 M, while Cell Source, Inc. made a net loss of $5 M.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

02444887329762020202120222023202420252026Cell Source, Inc. 69Seres Therapeutics, Inc. 9

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Seres Therapeutics, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCell Source, Inc.
CLCS
Seres Therapeutics, Inc.
MCRB · #24,348 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded—2010
Size
Market cap$20 M*$20 M
Revenue—$1 M
Net income$-5 M$6 M▲ best
Employees—333
Valuation
P/E ratio—3.5×
Price to sales—25.2×
Price to book—0.5×
Free cash flow yield—4.4%
Profitability
Return on equity—19.7%
Altman Z-score zone—distress
Data as ofMarket cap Dec 2022; ratios FY2024Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Cell Source, Inc. or Seres Therapeutics, Inc.?

Cell Source, Inc. and Seres Therapeutics, Inc. are worth about the same: $20 M and $20 M (market caps of Dec 25, 2022 for Cell Source, Inc. and Oct 30, 2026 for Seres Therapeutics, Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, Cell Source, Inc. or Seres Therapeutics, Inc.?

Seres Therapeutics, Inc. made a net profit of $6 M, while Cell Source, Inc. made a net loss of $5 M.